Adaptimmune Therapeutics PLC (ADAP)
1.01
-0.03
(-2.88%)
USD |
NASDAQ |
Jun 14, 16:00
1.015
0.00 (0.00%)
After-Hours: 20:00
Adaptimmune Therapeutics Accounts Payable (Quarterly): 6.587M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.587M |
December 31, 2023 | 8.128M |
September 30, 2023 | 13.92M |
June 30, 2023 | 14.71M |
March 31, 2023 | 5.187M |
December 31, 2022 | 4.753M |
September 30, 2022 | 6.905M |
June 30, 2022 | 15.99M |
March 31, 2022 | 7.017M |
December 31, 2021 | 8.113M |
September 30, 2021 | 4.784M |
June 30, 2021 | 6.977M |
March 31, 2021 | 4.116M |
December 31, 2020 | 6.389M |
September 30, 2020 | 4.03M |
June 30, 2020 | 8.766M |
March 31, 2020 | 7.066M |
December 31, 2019 | 6.357M |
Date | Value |
---|---|
September 30, 2019 | 5.535M |
June 30, 2019 | 4.344M |
March 31, 2019 | 5.391M |
December 31, 2018 | 4.083M |
September 30, 2018 | 3.907M |
June 30, 2018 | 4.131M |
March 31, 2018 | 5.051M |
December 31, 2017 | 8.378M |
September 30, 2017 | 2.489M |
June 30, 2017 | 4.577M |
March 31, 2017 | 5.177M |
December 31, 2016 | 11.35M |
September 30, 2016 | 3.193M |
June 30, 2016 | 2.474M |
March 31, 2016 | 2.44M |
September 30, 2015 | 4.667M |
December 31, 2014 | 45.85M |
June 30, 2014 | 1.012M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
4.03M
Minimum
Sep 2020
15.99M
Maximum
Jun 2022
7.484M
Average
6.746M
Median
Accounts Payable (Quarterly) Benchmarks
Biodexa Pharmaceuticals Plc | 0.40M |
NuCana PLC | 7.277M |
Autolus Therapeutics PLC | 1.399M |
TC BioPharm (Holdings) PLC | 2.434M |
Mereo BioPharma Group PLC | 2.455M |